Monthly Archives: March 2023

//March

Extension to Paracetamol 240mg suppositories (SSP051)

Update 05/05/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Paracetamol 240mg suppository (SSP051) was due to expire 5 May 2023 but have been further extended to Friday 12 May 2023. In response to a significant ongoing disruption to the supply of Paracetamol [...]

The post Extension to Paracetamol 240mg suppositories (SSP051) appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on Extension to Paracetamol 240mg suppositories (SSP051)

Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP049 Estradot® 100mcg patches expires at 23.59pm on Friday 17 March 2023. After this date, any prescriptions for Estradot® 100mcg patches must be [...]

The post Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches

MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch [...]

The post MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.

By |March 17th, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

Free clinical examination skills training for community pharmacists

Health Education England (HEE) has announced a new NHS-funded training course for 10,000 community pharmacists on clinical examination skills. The training, which will be coordinated by HEE with the Pharmacy Integration Programme at NHS England, will be provided by CliniSkills. The training will be delivered online, with optional face-to-face attendance for pharmacists who would find [...]

The post Free clinical examination skills training for community pharmacists appeared first on PSNC Website.

By |March 16th, 2023|Lexpos News|Comments Off on Free clinical examination skills training for community pharmacists

Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream. MSN/2023/028 Tier 2 – medium impact Date of issue 16th March 2023 Following intermittent supplies of capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream, these are now out of stock until end of June 2023. [...]

The post Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream appeared first on PSNC Website.

By |March 16th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Capsaicin 0.075% (Axsain®) and 0.025% (Zacin®) cream